Flying Eagle Shareholders Vote Yes on Skillz Merger

At deal announcement in October, terms called for Estrella Biopharma to receive the SPAC’s $45.4 million of cash held in trust at that time. However, ahead of a January extension vote, redemptions erased about 78% from the SPAC’s cash in trust.